Fig. 1From: Social capital and willingness to participate in COVID-19 vaccine trials: an Italian case-control studyORs and 95% CIs of estimated likelihood of participating in a COVID-19 vaccine clinical trial by social capital. Panel (a) General trust; Panel (b) Reciprocity – 1; Panel (c) Reciprocity – 2; Panel (d) Improve things; Panel (e) Vote; Panel (f) Social activities; Panel (g) Social capital indexBack to article page